Literature DB >> 27496516

Characterization of enteropathogenic Escherichia coli of clinical origin from the pediatric population in Pakistan.

Mahwish Younas1, Fariha Siddiqui1, Zobia Noreen1, Syeda Sadia Bokhari2, Oscar G Gomez-Duarte3, Brendan W Wren4, Habib Bokhari5.   

Abstract

BACKGROUND: Enteropathogenic Escherichia coli (EPEC) is one of the leading causes of watery diarrhea among children.
METHODS: In this study EPEC isolates from the pediatric population of Pakistan (2010-2012) were subjected to phylotyping, antibiotic susceptibility, extended-spectrum beta-lactamase (ESBL) profiling and evaluation of one representative strain from each panel of phylotypesin Galleria mellonella, infection model.
RESULTS: A total of 46/225 (20.4%) stool samples were positive for EPEC. Isolates mainly belong to D phylogroup (18, 39%) followed by nontypeable (10, 22%), B1 (9, 20%), B2 (8, 17%) and A (1, 2%). High resistance was observed for ampicillin (42, 91%), erythromycin (41, 89%), cefaclor (37, 80%), trimethoprim/sulfamethoxazole (36, 78%), tetracycline (36, 78%). Among nalidixic acid resistant isolates 13 (28%) showed presence of single nucleotide polymorphism (SNP) in parC (C330-T330) whereas 1 (2%) isolate showed gyrB (A660-T660) SNP. Furthermore, 27 (59%) isolates were ESBL producers. Representative isolates of phlyotypes A and B2 showed enhance killing of G. mellonella compared to ones belonging to phylotypes B1 and D.
CONCLUSIONS: Non-typeable EPEC strains were frequently observed. ESBL production in ESBL producers was found to be plasmid mediated. No significant association of antibiotic resistance profile with specific phylogroup of EPEC was found, however G. mellonella infection model differentiated representative phylotypes.
© The Author 2016. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Antibiotic resistance; Enteropathogenic Escherichia coli; Extended spectrum beta-lactamases; Galleria mellonella; Phylogroups; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2016        PMID: 27496516     DOI: 10.1093/trstmh/trw047

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

1.  Escherichia coli B2 Phylogenetic Subgroups in the Infant Gut Microbiota: Predominance of Uropathogenic Lineages in Swedish Infants and Enteropathogenic Lineages in Pakistani Infants.

Authors:  Forough L Nowrouzian; Olivier Clermont; Mona Edin; Anna Östblom; Erick Denamur; Agnes E Wold; Ingegerd Adlerberth
Journal:  Appl Environ Microbiol       Date:  2019-11-27       Impact factor: 4.792

2.  Molecular characterization of diarrheagenic Escherichia coli pathotypes: Association of virulent genes, serogroups, and antibiotic resistance among moderate-to-severe diarrhea patients.

Authors:  Nutan Thakur; Swapnil Jain; Harish Changotra; Rahul Shrivastava; Yashwant Kumar; Neelam Grover; Jitendraa Vashistt
Journal:  J Clin Lab Anal       Date:  2018-01-21       Impact factor: 2.352

3.  Characterization of Antimicrobial Susceptibility, Extended-Spectrum β-Lactamase Genes and Phylogenetic Groups of Enteropathogenic Escherichia coli Isolated from Patients with Diarrhea.

Authors:  Erfaneh Jafari; Saeid Mostaan; Saeid Bouzari
Journal:  Osong Public Health Res Perspect       Date:  2020-10

4.  Antibiotic resistance in Pakistan: a systematic review of past decade.

Authors:  Hazrat Bilal; Muhammad Nadeem Khan; Tayyab Rehman; Muhammad Fazal Hameed; Xingyuan Yang
Journal:  BMC Infect Dis       Date:  2021-03-06       Impact factor: 3.090

5.  Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006-2018.

Authors:  Dania Khalid Saeed; Joveria Farooqi; Sadia Shakoor; Rumina Hasan
Journal:  BMC Infect Dis       Date:  2021-12-07       Impact factor: 3.090

Review 6.  Extended-spectrum beta-lactamase-producing strains among diarrhoeagenic Escherichia coli-prospective traveller study with literature review.

Authors:  Anu Kantele; Tinja Lääveri
Journal:  J Travel Med       Date:  2022-01-17       Impact factor: 8.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.